Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H32O4 |
| Molecular Weight | 372.4978 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCC1=C(C(=O)OC)C(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1
InChI
InChIKey=GSBCCWIIKCFQKI-ZWKOTPCHSA-N
InChI=1S/C23H32O4/c1-6-7-8-9-16-13-19(24)21(22(25)20(16)23(26)27-5)18-12-15(4)10-11-17(18)14(2)3/h12-13,17-18,24-25H,2,6-11H2,1,3-5H3/t17-,18+/m0/s1
| Molecular Formula | C23H32O4 |
| Molecular Weight | 372.4978 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:53:51 GMT 2023
by
admin
on
Sat Dec 16 19:53:51 GMT 2023
|
| Record UNII |
X24LLC5PAP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
920722
Created by
admin on Sat Dec 16 19:53:52 GMT 2023 , Edited by admin on Sat Dec 16 19:53:52 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
55658-71-4
Created by
admin on Sat Dec 16 19:53:52 GMT 2023 , Edited by admin on Sat Dec 16 19:53:52 GMT 2023
|
PRIMARY | |||
|
11132454
Created by
admin on Sat Dec 16 19:53:52 GMT 2023 , Edited by admin on Sat Dec 16 19:53:52 GMT 2023
|
PRIMARY | |||
|
X24LLC5PAP
Created by
admin on Sat Dec 16 19:53:52 GMT 2023 , Edited by admin on Sat Dec 16 19:53:52 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->NEGATIVE ALLOSTERIC MODULATOR (NAM) |
Assumed from CBD and CBDA
|
||
|
TARGET -> ACTIVATOR |
Enhances activation after agonist binding
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
